Creative Medical Technology Holdings, Inc. (CELZ) Balance Sheet
CELZ balance sheet, 2025
December 31, 2025 · U.S. dollars$7.8M assets = $284,880 liabilities + $7.5M equity
Both columns are drawn to the same scale: what CELZ owns equals what it owes plus shareholders’ equity. Hover a block for its value.
CELZ financial health
Descriptive bands, not a rating. Fiscal 2025.
CELZ balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $322,5122016 | $7.8M2025 | +42.5%/yr | |
| Total liabilities | $480,3032016 | $284,8802025 | −5.6%/yr | |
| Shareholders’ equity | −$157,7912016 | $7.5M2025 | — | |
| Cash & short-term investments | $221,8682016 | $7.2M2025 | +47.2%/yr | |
| Total debt | $125,0002016 | $14,1942025 | −21.5%/yr | |
| Net cash (debt) | $96,8682016 | $7.2M2025 | +$7.1M | |
| Working capital | −$231,9962016 | $7.1M2025 | +$7.3M | |
| Debt / equity | 0.002021 | 0.002025 | 0.00 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
CELZ assets
CELZ liabilities and equity
CELZ debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
CELZ balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $7.2M | $5.9M | $10.0M | $18.4M | $10.7M | $98,012 | $88,648 | $304,056 | $13,697 | $221,868 |
| Cash & equivalents | $7.2M | $5.9M | $3.5M | $8.3M | $10.7M | $98,012 | $88,648 | $304,056 | $13,697 | $221,868 |
| Short-term investments | — | $0 | $6.5M | $10.1M | $0 | — | — | — | — | — |
| Receivables | $52,084 | $0 | $0 | −$10.1M | $2,485 | $0 | $5,600 | $9,600 | $4,801 | $0 |
| Inventory | $0 | $2,194 | $6,594 | $10,194 | $10,866 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $138,804 | $192,707 | $277,246 | $10.4M | $0 | $0 | $0 | $0 | $0 | $0 |
| Total current assets | $7.4M | $6.1M | $10.3M | $18.7M | $10.7M | $98,012 | $94,248 | $313,656 | $18,498 | $221,868 |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $407,230 | $530,559 | $441,011 | $435,595 | $527,679 | $619,763 | $436,555 | $163,505 | $184,649 | $100,644 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $3,281 | $3,281 | $3,281 | $3,281 | $3,281 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $7.8M | $6.7M | $10.7M | $19.2M | $11.3M | $717,775 | $530,803 | $477,161 | $203,147 | $322,512 |
| Liabilities | ||||||||||
| Accounts payable | $270,686 | $273,530 | $317,280 | $3.3M | $761,862 | $350,899 | $320,785 | $331,838 | $237,566 | $66,385 |
| Short-term debt | $14,194 | $14,194 | $14,194 | $14,194 | $14,194 | $788,701 | $1.1M | $682,056 | $501,748 | $102,600 |
| Deferred revenue | — | — | −$14,194 | −$14,194 | −$14,194 | $639,353 | $371,374 | $10,800 | $375,890 | $2,600 |
| Total current liabilities | $284,880 | $327,644 | $371,394 | $3.3M | $1.1M | $40.5M | $8.6M | $4.5M | $2.4M | $453,864 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $915 | $25,000 |
| Other long-term liabilities | $0 | $0 | $0 | $3.3M | $761,862 | $1.1M | $1.4M | $0 | $3,211 | $1,439 |
| Total liabilities | $284,880 | $327,644 | $371,394 | $3.3M | $1.1M | $40.5M | $8.6M | $4.5M | $2.4M | $480,303 |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $3,144 | $1,749 | $1,431 | $1,407 | $6,339 | $768,536 | $22,489 | $902,711 | $114,800 | $105,014 |
| Retained earnings (deficit) | −$70.6M | −$64.6M | −$59.1M | −$53.8M | −$43.7M | −$61.9M | −$25.6M | −$17.1M | −$3.4M | −$766,572 |
| Accumulated other comprehensive income | — | — | $0 | $0 | $0 | — | — | — | — | $0 |
| Minority interest | $10,000 | $0 | — | — | — | — | — | — | — | — |
| Total shareholders' equity | $7.5M | $6.3M | $10.3M | $15.9M | $10.2M | −$39.8M | −$8.1M | −$4.0M | −$2.2M | −$157,791 |
| Key figures | ||||||||||
| Total debt | $14,194 | $14,194 | $14,194 | $14,194 | $14,194 | $788,701 | $1.1M | $682,056 | $513,463 | $125,000 |
| Net cash (debt) | $7.2M | $5.9M | $10.0M | $18.4M | $10.7M | −$690,689 | −$973,618 | −$378,000 | −$499,766 | $96,868 |
| Working capital | $7.1M | $5.8M | $9.9M | $15.4M | $9.7M | −$40.4M | −$8.5M | −$4.2M | −$2.4M | −$231,996 |
| Tangible book value | $7.1M | $5.8M | $9.9M | $15.4M | $9.7M | −$40.4M | −$8.5M | −$4.2M | −$2.4M | −$258,435 |
| Book value per share | $3.15 | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 2.4M | — | — | — | — | — | — | — | — | — |
| Current ratio | 25.97 | 18.73 | 27.65 | 5.64 | 10.22 | 0.00 | 0.01 | 0.07 | 0.01 | 0.49 |
| Quick ratio | 25.49 | 18.13 | 26.89 | 2.50 | 10.21 | 0.00 | 0.01 | 0.07 | 0.01 | 0.49 |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
| Equity / assets | 96.2% | 95.1% | 96.5% | 82.7% | 90.7% | −5,545.3% | −1,520.6% | −837.2% | −1,100.8% | −48.9% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $8.7M | $5.8M | $7.2M | $5.4M | $6.5M | $7.7M | $5.9M | $6.3M | $7.5M | $9.0M | $10.0M | $12.0M |
| Cash & equivalents | $8.7M | $5.7M | $7.2M | $5.4M | $6.5M | $7.7M | $5.9M | $6.3M | $7.5M | $9.0M | $3.5M | $4.5M |
| Short-term investments | $125,000 | $125,000 | — | — | — | — | $0 | $0 | $0 | $6.5M | $6.5M | $7.5M |
| Receivables | $109,338 | $105,711 | $52,084 | $0 | $0 | $0 | $0 | $0 | $0 | $1 | $0 | $0 |
| Inventory | $125,000 | $0 | $0 | $994 | $994 | $994 | $2,194 | $3,394 | $3,394 | $6,594 | $6,594 | $7,794 |
| Other current assets | $70,460 | $105,032 | $138,804 | $35,036 | $87,593 | $140,150 | $192,707 | $67,608 | $129,086 | $190,563 | $277,246 | $61,478 |
| Total current assets | $9.0M | $6.1M | $7.4M | $5.4M | $6.6M | $7.8M | $6.1M | $6.3M | $7.6M | $9.2M | $10.3M | $12.0M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $355,459 | $378,377 | $407,230 | $438,181 | $469,240 | $499,982 | $530,559 | $553,198 | $382,469 | $411,740 | $441,011 | $466,532 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $3,281 | $3,281 | $3,281 | $3,281 | $3,281 | $3,281 | $3,281 | $3,281 | $3,281 | $3,281 | $3,281 | $3,281 |
| Total assets | $9.4M | $6.4M | $7.8M | $5.9M | $7.1M | $8.3M | $6.7M | $6.9M | $8.0M | $9.6M | $10.7M | $12.5M |
| Liabilities | ||||||||||||
| Accounts payable | $684,401 | $293,455 | $270,686 | $247,159 | $263,450 | $272,193 | $273,530 | $273,794 | $322,158 | $336,845 | $317,280 | $367,045 |
| Short-term debt | — | $14,194 | $14,194 | $14,194 | $14,194 | $14,194 | $14,194 | $14,194 | $14,194 | $14,194 | $14,194 | $14,194 |
| Deferred revenue | — | — | — | — | — | — | — | — | −$14,194 | −$14,194 | −$14,194 | −$14,194 |
| Total current liabilities | $698,595 | $307,649 | $284,880 | $261,353 | $277,644 | $286,387 | $327,644 | $330,908 | $376,272 | $390,959 | $371,394 | $421,159 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total liabilities | $698,595 | $307,649 | $284,880 | $261,353 | $277,644 | $286,387 | $327,644 | $330,908 | $376,272 | $390,959 | $371,394 | $421,159 |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $6,491 | $3,144 | $3,144 | $2,586 | $2,586 | $2,586 | $1,749 | $1,431 | $1,431 | $1,431 | $1,431 | $1,431 |
| Retained earnings (deficit) | −$73.5M | −$72.0M | −$70.6M | −$68.7M | −$67.5M | −$66.2M | −$64.6M | −$62.7M | −$61.7M | −$60.1M | −$59.1M | −$57.4M |
| Accumulated other comprehensive income | — | — | — | $0 | — | — | — | −$69.3M | −$1,431 | $0 | $0 | $0 |
| Minority interest | $24,086 | $23,360 | $10,000 | — | — | — | — | — | — | — | — | — |
| Total shareholders' equity | $8.7M | $6.1M | $7.5M | $5.6M | $6.8M | $8.1M | $6.3M | $6.6M | $7.6M | $9.2M | $10.3M | $12.1M |
| Key figures | ||||||||||||
| Total debt | — | $14,194 | $14,194 | $14,194 | $14,194 | $14,194 | $14,194 | $14,194 | $14,194 | $14,194 | $14,194 | $14,194 |
| Net cash (debt) | — | $5.8M | $7.2M | $5.4M | $6.5M | $7.7M | $5.9M | $6.2M | $7.5M | $9.0M | $10.0M | $12.0M |
| Working capital | $8.3M | $5.8M | $7.1M | $5.2M | $6.4M | $7.6M | $5.8M | $6.0M | $7.2M | $8.8M | $9.9M | $11.6M |
| Tangible book value | $8.3M | $5.7M | $7.1M | $5.2M | $6.4M | $7.6M | $5.8M | $6.0M | $7.2M | $8.8M | $9.9M | $11.6M |
| Book value per share | $2.34 | $1.65 | $3.15 | $2.17 | $2.65 | $4.07 | $3.84 | — | — | — | — | — |
| Shares outstanding | 3.7M | 3.7M | 2.4M | 2.6M | 2.6M | 2.0M | 1.7M | — | — | — | — | — |
| Current ratio | 12.91 | 19.69 | 25.97 | 20.71 | 23.89 | 27.39 | 18.73 | 19.13 | 20.21 | 23.54 | 27.65 | 28.60 |
| Quick ratio | 12.63 | 19.35 | 25.49 | 20.57 | 23.57 | 26.90 | 18.13 | 18.92 | 19.86 | 23.04 | 26.89 | 28.43 |
| Debt / equity | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity / assets | 92.3% | 94.9% | 96.2% | 95.5% | 96.1% | 96.6% | 95.1% | 95.2% | 95.3% | 95.9% | 96.5% | 96.6% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 20, 2026); data from EODHD.
CELZ financial position
At the end of fiscal 2025 (December 31, 2025), Creative Medical Technology had total assets of $7.8 million (up 17.1% from a year earlier), total liabilities of $0.3 million and shareholders' equity of $7.5 million. It held $7.2 million in cash and short-term investments against $0.0 million of debt, a net cash position of $7.2 million. Its current ratio was 25.97. In the latest quarter (ended June 30, 2026) total assets were $9.4 million and equity $8.7 million.
Related: CELZ income statement, CELZ cash flow statement, CELZ key metrics. See the CELZ stock overview for the latest quote and news.
CELZ balance sheet FAQ
What are Creative Medical Technology's total assets?
Creative Medical Technology reported total assets of $7.8 million at the end of fiscal 2025 (December 31, 2025), compared with $6.7 million a year earlier.
How much debt does Creative Medical Technology have?
Creative Medical Technology had $0.0 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.00.
How much cash does Creative Medical Technology have?
Creative Medical Technology held $7.2 million in cash and short-term investments at the end of fiscal 2025; with $0.0 million of debt that is net cash of $7.2 million.
What is Creative Medical Technology's book value?
Creative Medical Technology's shareholders' equity (book value) was $7.5 million at the end of fiscal 2025, or $3.15 per share.
What is Creative Medical Technology's current ratio?
Creative Medical Technology had current assets of $7.4 million and current liabilities of $0.3 million, a current ratio of 25.97 (it can cover its short-term obligations).
How much goodwill does Creative Medical Technology have?
Creative Medical Technology carried $0.4 million of goodwill and intangible assets, 5.2% of total assets, at the end of fiscal 2025.